Protein C inhibitor (PCI) binds to phosphatidylserine exposing cells with implications in the phagocytosis of apoptotic cells and activated platelets

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Rieger, Daniela ^a   Assinger, Alice ^a   Einfinger, Katrin ^a   Sokolikova, Barbora ^a   Geiger, Margarethe ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; PHORBOL ESTER; PHOSPHATIDYLSERINE; PLASMINOGEN ACTIVATOR INHIBITOR 3; POLYSTYRENE; CAMPTOTHECIN; MICROSPHERE; POLYSTYRENE DERIVATIVE; PROTEIN BINDING;

ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; JURKAT CELL LINE; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; THROMBOCYTE ACTIVATION; U937 CELL LINE; UPREGULATION; APOPTOSIS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; THROMBOCYTE;

APOPTOSIS; BLOOD PLATELETS; CAMPTOTHECIN; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; HUMANS; MACROPHAGES; MICROSPHERES; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; POLYSTYRENES; PROTEIN BINDING; PROTEIN C INHIBITOR; PROTEIN TRANSPORT;

EID: 84904280656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101794     Document Type: Article

References (37)

1. Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, et al. (1987) Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. J Biol Chem 262: 611-616. (Pubitemid 17005226)
2. Marlar RA, Griffin JH (1980) Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 66: 1186-1189. (Pubitemid 11233824)
3. Meijers JC, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, et al. (1988) Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 27: 4231-4237.
4. España F, Berrettini M, Griffin JH (1989) Purification and characterization of plasma protein C inhibitor. Thromb Res 55: 369-384. (Pubitemid 19221920)
5. Carroll VA, Griffiths MR, Geiger M, Merlo C, Furlan M, et al. (1997) Plasma protein C inhibitor is elevated in survivors of myocardial infarction. Arterioscler Thromb Vasc Biol 17: 114-118. (Pubitemid 27057332)
6. Nilsson G, Strandberg K, Astermark J, Vernersson E, Stenflo J, et al. (2007) The APC-PCI complex concentration predicts outcome of aortic surgery. Thromb Res 120: 237-244. (Pubitemid 46754422)
7. Watanabe R, Wada H, Sakakura M, Mori Y, Nakasaki T, et al. (2000) Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states. Am J Hematol 65: 35-40.
8. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S (1984) Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 95: 187-195. (Pubitemid 14177969)
9. Kuhn (1990) Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.
10. Shen L, Villoutreix BO, Dahlbäck B (1999) Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor. Thromb Haemost 82: 72-79. (Pubitemid 29368776)
11. Shirk RA, Elisen MG, Meijers JC, Church FC (1994) Role of the H helix in heparin binding to protein C inhibitor. J Biol Chem 269: 28690-28695. (Pubitemid 24366704)
12. Réhault SM, Zechmeister-Machhart M, Fortenberry YM, Malleier J, Binz NM, et al. (2005) Characterization of recombinant human protein C inhibitor expressed in Escherichia coli. Biochim Biophys Acta 1748: 57-65. (Pubitemid 40332180)
13. Malleier JM, Oskolkova O, Bochkov V, Jerabek I, Sokolikova B, et al. (2007) Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. Blood 109: 4769-4776. (Pubitemid 46827770)
14. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, et al. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216.
15. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL (2001) Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 276: 1071-1077. (Pubitemid 32096530)
16. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, et al. (2006) Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 203: 2613- 2625.
17. Kobayashi N, Karisola P, Peña-Cruz V, Dorfman DM, Jinushi M, et al. (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940. (Pubitemid 50014866)
18. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, et al. (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-187. (Pubitemid 34506799)
19. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, et al. (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 4: 87-91. (Pubitemid 36113217)
20. Kenis H, van Genderen H, Deckers NM, Lux PA, Hofstra L, et al. (2006) Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res 312: 719-726.
21. Liu G, Wang J, Park YJ, Tsuruta Y, Lorne EF, et al. (2008) High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 181: 4240-4246.
22. Zhang WJ, Hufnagl P, Binder BR, Wojta J (2003) Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 90: 904-914. (Pubitemid 37427861)
23. Huber J, Boechzelt H, Karten B, Surboeck M, Bochkov VN, et al. (2002) Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway. Arterioscler Thromb Vasc Biol 22: 581-586. (Pubitemid 34408737)
24. Schuster C, Fernbach N, Rix U, Superti-Furga G, Holy M, et al. (2007) Selective serotonin reuptake inhibitors-a new modality for the treatment of lymphoma/ leukaemia? Biochem Pharmacol 74: 1424-1435. (Pubitemid 47445448)
25. Lemarie A, Morzadec C, Mérino D, Micheau O, Fardel O, et al. (2006) Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. J Pharmacol Exp Ther 316: 304-314. (Pubitemid 41832610)
26. Zhao KW, Li X, Zhao Q, Huang Y, Li D, et al. (2004) Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 104: 3731-3738. (Pubitemid 39564451)
27. Badrnya S, Schrottmaier WC, Kral JB, Yaiw KC, Volf I, et al. (2014) Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler Thromb Vasc Biol 34: 571-580.
28. Assinger A, Koller F, Schmid W, Zellner M, Babeluk R, et al. (2010) Specific binding of hypochlorite-oxidized HDL to platelet CD36 triggers proinflammatory and procoagulant effects. Atherosclerosis 212: 153-160.
29. Callahan MK, Halleck MS, Krahling S, Henderson AJ, Williamson P, et al. (2003) Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells. J Leukoc Biol 74: 846-856. (Pubitemid 38040361)
30. Bevers EM, Comfurius P, Zwaal RF (1983) Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 736: 57-66. (Pubitemid 14201823)
31. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, et al. (1990) Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 265: 4923-4928.
32. Baumgärtner P, Geiger M, Zieseniss S, Malleier J, Huntington JA, et al. (2007) Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor. J Cell Biol 179: 793-804. (Pubitemid 350146262)
33. Kenis H, van Genderen H, Bennaghmouch A, Rinia HA, Frederik P, et al. (2004) Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem 279: 52623-52629. (Pubitemid 39656638)
34. Park YJ, Liu G, Lorne EF, Zhao X, Wang J, et al. (2008) PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci U S A 105: 11784-11789.
35. Maugeri N, Rovere-Querini P, Evangelister V, Covino C, Capobianco A, et al. (2009) Neutrophils phagocytose activated platelets in vivo: a phosphatidylserien, P-selectin, and {beta}2 integrin dependent cell clearance program. Blood 113: 5254-65.
36. Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, et al. (2005) Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7: 808-816. (Pubitemid 41079053)
37. Malmström E, Mörgelin M, Malmsten M, Johansson L, Norrby-Teglund A, et al. (2009) Protein C inhibitor-a novel antimicrobial agent. PLoS Pathog 5: e1000698.